$GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study$

GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation. Heart failure 2014-07, Vol.7 (4), p.673-679
Hauptverfasser:	Margulies, Kenneth B, Anstrom, Kevin J, Hernandez, Adrian F, Redfield, Margaret M, Shah, Monica R, Braunwald, Eugene, Cappola, Thomas P
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Clinical Trials as Topic - methods Glucagon-Like Peptide 1 - agonists Glucagon-Like Peptide 1 - metabolism Heart Failure - drug therapy Heart Failure - metabolism Heart Failure - physiopathology Humans Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Stroke Volume - drug effects Treatment Outcome Ventricular Function, Left - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	1941-3289 1941-3297
DOI:	10.1161/CIRCHEARTFAILURE.114.000346